MX356052B - Terapias sinergicas de cannabidiol con hipotermia para neuroproteccion. - Google Patents

Terapias sinergicas de cannabidiol con hipotermia para neuroproteccion.

Info

Publication number
MX356052B
MX356052B MX2014014839A MX2014014839A MX356052B MX 356052 B MX356052 B MX 356052B MX 2014014839 A MX2014014839 A MX 2014014839A MX 2014014839 A MX2014014839 A MX 2014014839A MX 356052 B MX356052 B MX 356052B
Authority
MX
Mexico
Prior art keywords
neuroprotection
cannabidiol
hypothermia
synergistic therapies
therapies
Prior art date
Application number
MX2014014839A
Other languages
English (en)
Other versions
MX2014014839A (es
Inventor
Guy Geoffrey
Martinez-Orgado José
Original Assignee
Gw Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gw Pharma Ltd filed Critical Gw Pharma Ltd
Publication of MX2014014839A publication Critical patent/MX2014014839A/es
Publication of MX356052B publication Critical patent/MX356052B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0054Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water
    • A61F2007/0056Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water for cooling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02Compresses or poultices for effecting heating or cooling

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Vascular Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a la combinación del fitocannabinoide cannabidiol con hipotermia terapéutica para usarse en el tratamiento de neuroprotección o astroprotección.
MX2014014839A 2012-06-08 2013-06-10 Terapias sinergicas de cannabidiol con hipotermia para neuroproteccion. MX356052B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1210142.4A GB2504263B (en) 2012-06-08 2012-06-08 Synergistic therapies for neuroprotection
PCT/GB2013/051519 WO2013182862A1 (en) 2012-06-08 2013-06-10 Synergistic therapies of cannabidiol with hypothermia for neuroprotection

Publications (2)

Publication Number Publication Date
MX2014014839A MX2014014839A (es) 2015-02-12
MX356052B true MX356052B (es) 2018-05-11

Family

ID=46605623

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014014839A MX356052B (es) 2012-06-08 2013-06-10 Terapias sinergicas de cannabidiol con hipotermia para neuroproteccion.

Country Status (18)

Country Link
US (1) US10220005B2 (es)
EP (1) EP2858633B1 (es)
JP (1) JP6284525B2 (es)
BR (1) BR112014030406A8 (es)
CA (1) CA2874968C (es)
CY (1) CY1118118T1 (es)
DK (1) DK2858633T3 (es)
ES (1) ES2583830T3 (es)
GB (1) GB2504263B (es)
HR (1) HRP20160905T1 (es)
HU (1) HUE028822T2 (es)
MX (1) MX356052B (es)
PL (1) PL2858633T3 (es)
PT (1) PT2858633T (es)
RS (1) RS55029B1 (es)
SI (1) SI2858633T1 (es)
SM (1) SMT201600265B (es)
WO (1) WO2013182862A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2539472A (en) 2015-06-17 2016-12-21 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
DK3389653T3 (da) 2015-12-16 2024-01-02 Neurophyxia B V 2-iminobiotin til anvendelse i behandling af hjernecellelæsion
JP2019524655A (ja) 2016-06-29 2019-09-05 キャンサイエンス イノベーションズ インコーポレーテッドCannscience Innovations Inc. 脱炭酸大麻樹脂、その使用、及びそれを製造する方法
GB202002754D0 (en) 2020-02-27 2020-04-15 Gw Res Ltd Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
GB2597281A (en) * 2020-07-20 2022-01-26 Gw Res Ltd Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2434312B (en) 2006-01-18 2011-06-29 Gw Pharma Ltd Cannabinoid-containing plant extracts as neuroprotective agents
WO2009071096A2 (en) * 2007-12-05 2009-06-11 Neurokey A/S Combination of medical and physical cooling treatment of ischemic effects

Also Published As

Publication number Publication date
PT2858633T (pt) 2016-07-29
CA2874968C (en) 2020-02-18
HUE028822T2 (en) 2017-01-30
HRP20160905T1 (hr) 2016-09-23
GB2504263B (en) 2015-09-16
EP2858633B1 (en) 2016-07-13
GB2504263A (en) 2014-01-29
ES2583830T3 (es) 2016-09-22
SMT201600265B (it) 2016-08-31
JP6284525B2 (ja) 2018-02-28
PL2858633T3 (pl) 2016-11-30
WO2013182862A1 (en) 2013-12-12
US20160243054A2 (en) 2016-08-25
MX2014014839A (es) 2015-02-12
JP2015518875A (ja) 2015-07-06
RS55029B1 (sr) 2016-11-30
SI2858633T1 (sl) 2016-10-28
US20150148872A1 (en) 2015-05-28
EP2858633A1 (en) 2015-04-15
CA2874968A1 (en) 2013-12-12
DK2858633T3 (en) 2016-08-15
BR112014030406A8 (pt) 2021-06-22
BR112014030406A2 (pt) 2017-06-27
US20150328171A2 (en) 2015-11-19
CY1118118T1 (el) 2017-06-28
GB201210142D0 (en) 2012-07-25
US10220005B2 (en) 2019-03-05

Similar Documents

Publication Publication Date Title
IL269041A (en) Tesmelteon for use in the treatment of asynchronous circadian rhythm of cortisol
IL269852B (en) Combined treatments and uses for the treatment of demyelination disorders
PH12016501139A1 (en) Bicyclic heterocycle compounds and their uses in therapy
HK1222552A1 (zh) 索布替羅用於治療髓鞘形成疾病
MX356525B (es) Vectores de virus asociados con adeno (aav) para uso en terapia de genes de coroideremia.
HK1221408A1 (zh) 用於治療成膠質細胞瘤的組合療法
MX365835B (es) Uso de akkermansia para tratar trastornos metabolicos.
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
IL242386B (en) Use of Aribolin and Lavetinib as a combination therapy for cancer treatment
HK1204993A1 (en) Combination therapy for the treatment of glioblastoma
PL2804599T3 (pl) Terapia skojarzona do leczenia nowotworu złośliwego
EP3061452A4 (en) Use of icaritin in preparing medicament for preventing or treating hematocytopenia
PH12015500663A1 (en) Pharmaceutical combinations comprising dual angiopoietin-2/dll4 binders and anti-vegf-r agents
MX2014014839A (es) Terapias sinergicas de cannabidiol con hipotermia para neuroproteccion.
MX2014012535A (es) Terapia de combinacion de anticuerpos anti-mif y quimioterapeuticos.
MX369774B (es) Uso de pregn-4-en-20-in-3-ona para el tratamiento de trastornos depresivos.
IL233495A0 (en) Combination for cancer treatment
AU2012904010A0 (en) Combination therapy to reduce the risk of and to treat cancer
UA80747U (ru) Применение препарата октенисепт как средства для санации полостей суставов при лечении метаэпифизарного остеомиелита
UA67953U (ru) Установка для лечения вирусных гепатитов с использованием медицинского озона

Legal Events

Date Code Title Description
FG Grant or registration